Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-20T03:35:02.559Z Has data issue: false hasContentIssue false

Trial of ‘Piracetam’ in Chronic Schizophrenia

Published online by Cambridge University Press:  29 January 2018

I. G. Pryce
Affiliation:
Whitchurch Hospital, Whitchurch, Cardiff CF4 7XB
Charles Gray
Affiliation:
Whitchurch Hospital, Whitchurch, Cardiff CF4 7XB
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1978 

References

Abuzzahab, F. S., Merwin, G. E. & Sherman, M. C. (1973) A controlled investigation of Piracetam versus placebo on the memory of geriatric patients (abstract). The Pharmacologist, 15, 456 (abstract).Google Scholar
Beaumont, J. G. & Dimond, S. J. (1973) Brain disconnection and schizophrenia. British Journal of Psychiatry, 123, 661–2.CrossRefGoogle ScholarPubMed
Buresova, O. & Bures, J. (1976) Piracetam-induced facilitation of interhemispheric transfer of visual information in rat. Psychopharmacologia (Berl.), 46, 93102.CrossRefGoogle Scholar
Dencker, S. J. & Lindberg, D. (1977) A controlled double-blind study of Piracetam in the treatment of senile dementia. Nordisk Psykiatrisk Tidsskrift, 31, 4852.CrossRefGoogle Scholar
Rosenthal, R. & Bigelow, L. B. (1972) Quantitative brain measurements in chronic schizophrenia. British Journal of Psychiatry, 121, 259–64.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.